Miquel Vila Bover I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR) Institutions of which they are part Head of group Neurodegenerative Diseases Vall Hebron Institut de Recerca Miquel Vila Bover Institutions of which they are part Head of group Neurodegenerative Diseases Vall Hebron Institut de Recerca I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)
I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder. In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN). I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.
Projects NIPARK - Targeting neuromelanin-linked neuronal dysfunction and degeneration in ageing and Parkinson’s disease using a combined imaging and brain stimulation approach IP: Miquel Vila Bover Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: Reference: EC/ERANET_JNPD/2020/VILA Duration: - Sex-based modulation of neuromelanin-linked Parkinson’s disease pathology IP: Miquel Vila Bover Collaborators: Javier Hoyo Pérez, Gerard Roch Alba, Marta González Sepúlveda, Annabelle Parent Funding agency: Michael J. Fox Foundation Funding: 163538.22 Reference: SEX-NEUROMELANINE_M.VILA_MJFF_2020 Duration: 01/02/2021 - 31/12/2024 ACTUALIZACIÓN DE EQUIPAMIENTOS DE ALTA TECNOLOGIA PARA LA PLATAFORMA DE IMAGEN PRECLINICA. ADQUISICION DE UN EQUIPO DE IMAGEN OPTICA IP: Inmaculada Fuentes Camps Collaborators: César Serrano Garcia, Santiago Ramon y Cajal Agüeras, Miquel Vila Bover, ACTUALIZACIÓN DE EQUIPAMIENTOS DE ALTA TECNOLOGIA PARA LA PLATAFORMA DE IMAGEN PRECLINICA. ADQUISICION DE UN EQUIPO DE IMAGEN OP, Josep Tabernero Caturla, Francesc Bosch Albareda, Miguel Segura Ginard, Victor Franco Puntes, Mª Jesús Cruz Carmona, Simon Schwartz Navarro, Eva Muñoz Couselo, Joaquim Mateo Valderrama, Juan Angel Recio Conde, Anna Rosell Novel, Josep Roma Castanyer Funding agency: Ministerio Ciencia, Innovación y Universidades Funding: 134516.7 Reference: EQC2019-006306-P Duration: 01/01/2019 - 31/12/2020 ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UNIDAD DE ALTA TECNOLOGÍA (UAT) IP: Inmaculada Fuentes Camps Collaborators: Miquel Vila Bover, ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UN, José García Arumí, Miguel Segura Ginard, Victor Franco Puntes, Anna Santamaria Margalef, Carmen Espejo Ruiz, María José Buzón Gómez, Javier Inserte Igual, Anna Rosell Novel, Trond Aasen Funding agency: Ministerio Ciencia, Innovación y Universidades Funding: 502000 Reference: EQC2019-006247-P Duration: 01/01/2019 - 31/12/2020 Pagination First page « Previous page ‹ … Page 2 Page 3 Current page 4 Page 5 Page 6 … Next page › Last page »